Cleveland Clinic Innovations, the hospital system's technology transfer and commercialization group, has launched a series of promising companies.

$28 million may be just the beginning.
That’s the return Cleveland Clinic received after the $78 million sale of Clinic spinoff Intelect Medical to Boston Scientific Corp. (NYSE:BSX).
Boston Scientific's Lotus TAVI system minimizes leakage in an early trial, St. Jude Medical gains on...
Electromed founder, chairman & CEO Robert Hansen announces his retirement after 20 years leading...
St. Jude Medical's shares get a 2% lift from an upgrade by a Goldman Sachs analyst.
Just weeks before a $2.3 billion acquisition by Asahi Kasei closed, the Securities & Exchange...
Boston Scientific's Synergy bioabsorbable drug-eluting stent proves just as good as its leading and...